Has been working at AstraZeneca Türkiye since June 1, 2020, Dr. Yiğit Kılıç M.D. was appointed as the leader of the Diagnostics Group established within the Medical Department as of March 1, 2024. In this role, Kılıç will be responsible for managing AstraZeneca Türkiye’s diagnostic strategy, developing collaborations and projects that will optimize diagnostic processes in the healthcare ecosystem, and improving the patient experience during the accurate diagnosis and treatment process.
Graduated from Faculty of Medicine of Istanbul University in 2010, after working in various public health institutions, Dr. Yiğit Kılıç took on different duties in the field of oncology at MSD Türkiye between 2016 and 2020. Kılıç, who joined AstraZeneca Türkiye as a Medical Manager in 2020, served as Senior Medical Manager in the oncology unit in 2021 between 2022 and 2023, Dr. Yiğit Kılıç served as the Middle East and Africa Region Lung Cancer Council Leader within the scope of the company’s Plan 100 development program.
